EyePoint, Inc. (EYPT)
0.3484
-0.03
(-8.32%)
USD |
NASDAQ |
Oct 30, 16:00
0.3403
-0.01
(-2.32%)
After-Hours: 20:00
EyePoint Cash and Short Term Investments (Annual) : 306.09M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 306.09M |
| December 31, 2024 | 370.91M |
| December 31, 2023 | 331.05M |
| December 31, 2022 | 144.56M |
| December 31, 2021 | 211.56M |
| December 31, 2020 | 44.91M |
| December 31, 2019 | 22.21M |
| December 31, 2018 | 45.26M |
| June 30, 2017 | 16.90M |
| June 30, 2016 | 28.99M |
| Date | Value |
|---|---|
| June 30, 2015 | 28.54M |
| June 30, 2014 | 18.28M |
| June 30, 2013 | 10.27M |
| June 30, 2012 | 14.57M |
| June 30, 2011 | 24.13M |
| June 30, 2010 | 17.56M |
| June 30, 2009 | 6.899M |
| June 30, 2008 | 15.61M |
| June 30, 2007 | 2.67M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ocular Therapeutix, Inc. | 737.06M |
| Regeneron Pharmaceuticals, Inc. | 8.611B |
| Corcept Therapeutics, Inc. | 372.15M |
| Eli Lilly & Co. | 7.268B |
| Context Therapeutics, Inc. | 66.00M |